2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   8

Issue No. :  4

Year :  2015

Pages :   395-403

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Allready Registrered
Click to Login

Once a daily Tablet Formulation and In Vitro Evaluation of HPMC Based Intra Gastric Floating Tablet of Levofloxacin

Address:   P.S Gangane1*, S. B. Sapkal2, A.S. Welankiwar2, P.S. Magar2, D.V. Bhusari2
1Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Besa, Nagpur
2Department of Pharmaceutics, IBSS College of Pharmacy, Malkapur, Dist. Buldana
*Corresponding Author
DOI No: 10.5958/0974-360X.2015.00067.0

The aim of this study was to develop a new intra-gastric floating tablet for controlled delivery of Levofloxacin for the treatment of peptic ulcer disease caused by Helicobacter pylori (H. pylori). The method of preparation is direct compression method. HPMC, K-grade and effervescent material sodium bicarbonate formed the floating layer. The release layer contained Levofloxacin and various polymers such as HPMC-K15M, HPMC-K100M, PVP-K30 and MCC in combination with the drug. The in vitro drug release was studied in pH 1.2 HCl using USP dissolution Apparatus II at 50 rpm. Zero-order, first-order, Higuchi and Korsmeyer et al. models were used to estimate the kinetics of drug release. Optimized formulation released approximately 98% drug in 12 h in vitro, while the floating lag time was 49 sec and the tablet remained floatable throughout all studies. Optimized formulation (D3) followed the Korsmeyer and Peppas model and showed no significant change in physical appearance, drug content, floatability and invitro dissolution pattern after storage at 45 0C/75% RH for three month.
H. pylori infection, Methocel matrices, swelling index, Data analysis.
P.S Gangane, S. B. Sapkal, A.S. Welankiwar, P.S. Magar, D.V. Bhusari. Once a daily Tablet Formulation and In Vitro Evaluation of HPMC Based Intra Gastric Floating Tablet of Levofloxacin. Research J. Pharm. and Tech. 8(4): April, 2015; Page 395-403.
[View HTML]      [View PDF]

Visitor's No. :   658608